News Daily News Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease Yael L. Maxwell September 15, 2017
News Industry News Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology September 07, 2017
News Daily News Appropriate Use Criteria Released for Imaging in Valvular Heart Disease Caitlin E. Cox September 06, 2017
Presentation iASSESS 2017 Valvular Heart Disease: Aortic Valvuloplasty and TAVR Presenter: Rahul Sakhuja, Zoltan Turi August 30, 2017
News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017
Presentation ESC 2017 Guidelines for the Management of Valvular Heart Disease Presenter: Helmut Baumgartner August 29, 2017
News Conference News ESC 2017 European Societies Issue New Valvular Heart Disease Guidelines, With Important Shifts Shelley Wood August 27, 2017
News Daily News TAVR in the US: Regional Variations in Numbers, Outcomes Michael O'Riordan August 22, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor L.A. McKeown July 26, 2017
News Daily News FDA Expands CoreValve Indication to Include Intermediate-Risk Patients Michael O'Riordan July 10, 2017
News Conference News SCCT 2017 Seeing Is Believing: Experts Predict an Expanded Role for Cardiac CT in Structural Interventions Yael L. Maxwell July 08, 2017
News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News TVT 2017 Volume Underload? More TAVRs Done, the Better the Operator Outcomes, Yet Many Patients Go Untreated Michael O'Riordan June 16, 2017
Presentation TVT 2017 Early Feasibility Studies in the U.S. With a Focus on Valvular Heart Disease: Updates, Impact, and Future Directions Presenter: John G. Webb, Robert B. Hance June 16, 2017
Presentation TVT 2017 Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference? Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy June 15, 2017